FDA Import Refusal SCS-1291645-2/11/1 — Novo Nordisk Pharma Ltd
The FDA refused shipment SCS-1291645-2/11/1 from Novo Nordisk Pharma Ltd (Japan) on Dec 11, 2023. The refused product falls under Drugs and Biologics — HUMAN GROWTH HORMONE (HORMONE). Cited charge: 75 This firm has 3 other import refusals on record.
Refusal details
- Date
- Dec 11, 2023
- Country
- Japan
- Product Category
- Drugs and Biologics
- Product Code
- 64RDY18 HUMAN GROWTH HORMONE (HORMONE)
- Charges
- 75